A metagenomic analysis of the virome of inverted papilloma and squamous cell carcinoma.
human papillomavirus
inverted papilloma
malignancy
p16
sinonasal
squamous cell carcinoma
Journal
International forum of allergy & rhinology
ISSN: 2042-6984
Titre abrégé: Int Forum Allergy Rhinol
Pays: United States
ID NLM: 101550261
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
revised:
30
04
2023
received:
26
03
2023
accepted:
10
05
2023
pubmed:
16
5
2023
medline:
16
5
2023
entrez:
16
5
2023
Statut:
ppublish
Résumé
Inverted papilloma (IP) is a sinonasal tumor with a well-known potential for malignant transformation. The role of human papillomavirus (HPV) in its pathogenesis has been controversial. The purpose of this study was to determine the virome associated with IP, with progression to carcinoma in situ (CIS), and invasive carcinoma. To determine the HPV-specific types, a metagenomics assay that contains 62,886 probes targeting viral genomes in a microarray format was used. The platform screens DNA and RNA from fixed tissues from eight controls, 16 IP without dysplasia, five IP with CIS, and 13 IP-associated squamous cell carcinoma (IPSCC). Paired with next-generation sequencing, 48 types of HPV with 857 region-specific probes were interrogated against the tumors. The prevalence of HPV-16 was 14%, 42%, 70%, and 73% in control tissue, IP without dysplasia, IP with CIS, and IPSCC, respectively. The prevalence of HPV-18 had a similar progressive increase in prevalence, with 14%, 27%, 67%, and 74%, respectively. The assay allowed region-specific analysis, which identified the only oncogenic HPV-18 E6 to be statistically significant when compared with control tissue. The prevalence of HPV-18 E6 was 0% in control tissue, 25% in IP without dysplasia, 60% in IP with CIS, and 77% in IPSCC. There are over 200 HPV types that infect human epithelial cells, of which only a few are known to be high-risk. Our study demonstrated a trend of increasing prevalence of HPV-18 E6 that correlated with histologic severity, which is novel and supports a potential role for HPV in the pathogenesis of IP.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2055-2062Informations de copyright
© 2023 ARS-AAOA, LLC.
Références
Mirza S, Bradley PJ, Acharya A, et al. Sinonasal inverted papillomas: recurrence, and synchronous and metachronous malignancy. J Laryngol Otol. 2007;121:857-864. Web of Science.
Choi JW, Kim SG, Kim YM, et al. Clinical and histologc features of inverted papilloma-associated malignancy. Eur Arch Otorhinolaryngol. 2012;269:2349-2354. Web of Science.
Lawson W, Patel ZM. The evolution of management for inverted papilloma: an analysis of 200 cases. Otolaryngol Head Neck Surg. 2009;140:330-335. Web of Science.
Woodworth BA, Bhargave GA, Palmer JN, et al. Clinical outcomes of endoscopic and endoscopic-assisted resection of inverted papillomas: a 15-year experience. Am J Rhinol. 2007;21:591-600. Web of Science.
Han JK, Smith TL, Loehrl T, et al. An evolution in the management of sinonasal inverting papilloma. Laryngoscope. 2001;111:1395-1400. Web of Science.
Suh JD, Chiu AG. What are the surveillance recommendations following resection of sinonasal inverted papilloma? Laryngoscope. 2014;124:1981-1982. Web of Science.
Yan CH, Newman JG, Kennedy DW, et al. Clinical outcomes of sinonasal squamous cell carcinomas based on tumor etiology. Int Forum Allergy Rhinol. 2017;7:508-513. Web of Science.
Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709-720. Web of Science.
Lindel K, Beer KT, Laissue J, et al. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer;92:805-813. Web of Science.
Reimers N, Kasper HU, Weissenborn SJ, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer. 2007;120:1731-1738. Web of Science.
Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006;24:736-747. Web of Science.
Lawson W, Schlecht NF, Brandwein-Gensler M. The role of the human papillomavirus inthe pathogenesis of Schneiderian inverted papillomas: an analytic overview of the evidence. Head Neck Pathol. 2008;2:49-59.
Justice JM, Davis KM, Saenz DA, et al. Evidence that human papillomavirus causes inverted papilloma is sparse. Int Forum Allergy Rhinol. 2014;4:995-1001. Web of Science.
Kim JY, Yoon JK, Citardi MJ, et al. The prevalence of human papilloma virus infection in sinonasal inverted papilloma specimens classified by histological grade. Am J Rhinol. 2007;21:664-669. Web of Science.
McKay SP, Gregoire L, Lonardo F, et al. Human papillomavirus (HPV) transcripts in malignant inverted papilloma are from integrated HPV DNA. Laryngoscope. 2005;115:1428-1431. Web of Science.
Stoddard DG Jr, Keeney MG, Gao G, et al. Transcriptional activity of HPV in inverted papilloma demonstrated by in situ hybridization for E6/E7 mRNA. Otolaryngol Head Neck Surg. 2015;152:752-758. Web of Science.
Syrjanen K, Syrjanen S. Detection of human papillomavirus in sinonasal papillomas: systematic review and meta-analysis. Laryngoscope. 2013;123:181-192. Web of Science.
Kim KY, Lewis JS Jr, Chen Z. Current status of clinical testing for human papillomavirus in oropharyngeal squamous cell carcinoma. J Pathol Clin Res. 2018;4:213-226.
Syrjanen S, Happonen RP, Virolainen E, et al. Detection of human papillomavirus (HPV) structural antigens and DNA types in inverted papillomas and squamous cellcarcinomas of the nasal cavities and paranasal sinuses. Acta Otolaryngol. 1987;104:334-341. Web of Science.
Udager AM, Rolland DCM, McHugh JB, et al. High-Frequency targetable EGFR mutations in sinonasal squamous cell carcinomas arising from inverted sinonasal papilloma. Cancer Res. 2015;75:2600-2606. Web of Science.